Lakewood-Amedex's Series C - II Round

Lakewood-Amedex raised a round of funding on September 11, 2015.

Lakewood-Amedex is a biopharmaceutical company developing a broad portfolio of innovative novel-approach anti-infective products in the treatment of serious infectious diseases, improving patient outc…

Articles about Lakewood-Amedex's Series C - II Round: